¿ÀÆÛ°Ô½ÃÆÇ |
|
|
ÀÔ·ÂÀÏÀÚ: |
2015-02-11 |
À¯È¿ÀÏÀÚ: |
183319-69-9 |
Á¦ ¸ñ:
|
Erlotinib hydrochloride |
»óÇ°ºÐ·ù: |
ÈÇкñ·á¿Í ³ó¾à |
µî·ÏºÐ·ù: |
Offer to Sell |
³» ¿ë: |
Erlotinib hydrochloride
Synonyms: ERLOTINIB HCL;ERLOTINIB HCL SALT;ERLOTINIB HCL SALT :TARCEVA;Erlotinib, Hydrochloride Salt;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, Hydrochloride Salt, OSI 774, Tarceva; N-(3-Ethynylphenyl)-6,7-bis-(2-methoxyethoxy)-quinazolin-4-amine;[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4yl]-(3-ethynyl-phenyl)-amine;Tarceva Hydrochloride See E625000
CAS: 183319-69-9
MF: C22H24ClN3O4
MW: 429.9
Chemical Properties Off-White Solid
Usage Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor. Antineoplastic
Usage Erlotinib HCl is an HER1/EGFR inhibitor with IC50 of 2 nM.
Usage Erlotinib HCl (OSI-744) is an EGFR inhibitor with IC50 of 2 nM, >1000-fold more sensitive for EGFR than human c-Src or v-Abl. Phase 3. |
¿¬¶ôó |
´ã
´ç ÀÚ: |
Ivy Young |
ȸ»çÁÖ¼Ò: |
No 496 Zhongshan Road, Wuhan City, Hubei Province, China 430064 |
¿ìÆí¹øÈ£: |
430064 |
ÀüȹøÈ£: |
86-027-50755963 |
Æѽº¹øÈ£:
|
86-027-50755963 |
E - mail: |
ycwlb045@yccreate.com |
|